Supplies & Consumables

Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, today announced the introduction of Prostate Px+, the first commercial test to predict prostate cancer progression and disease recurrence at the time of diagnosis.
| 2 min read








